Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2007
12/27/2007CA2666688A1 Reduced coenzyme q10-containing composition and method for producing the same
12/27/2007CA2655788A1 Skin external preparation containing triterpenic acid
12/27/2007CA2654493A1 Tablets comprising candesartan cilexetil
12/27/2007CA2654175A1 Fermentation and purification of actinomadura chromoprotein and related species
12/27/2007CA2653061A1 Stabilized proteins
12/27/2007CA2630903A1 Keratin-binding effector molecules, and method for the production thereof
12/26/2007EP1870115A1 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
12/26/2007EP1870110A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
12/26/2007EP1870100A1 Pharmaceutical composition for oral application comprising ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate mesylate
12/26/2007EP1870091A1 Liposome composition for induction of immunity
12/26/2007EP1870090A2 Novel stable formulation of suspended aerosols and production method thereof
12/26/2007EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer
12/26/2007EP1869092A1 Hydrophilic core polymeric micelles for the delivery of water-soluble compounds
12/26/2007EP1869079A2 Di-polymer protein conjugates and processes for their preparation
12/26/2007EP1868653A2 Hmgcoa reductase inhibitor codrugs and uses thereof
12/26/2007EP1868652A2 Method for shielding functional sites or epitopes on proteins
12/26/2007EP1868649A2 Elimination of heterogeneous or mixed cell population in tumors
12/26/2007EP1868646A2 Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent
12/26/2007EP1868624A2 Compositions comprising probiotic and sweetener components
12/26/2007EP1868620A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
12/26/2007EP1868594A1 Ganglionic blocking agents for the treatment of epithelial diseases
12/26/2007EP1868580A1 Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance
12/26/2007EP1868572A2 Administration of glutathione (reduced) via intravenous or encapsulated in liposome for treatment of tnf-alpha effects and elu-like viral symptoms
12/26/2007EP1868570A2 Methods and systems for operating an aerosol generator
12/26/2007EP1868452A1 Hydroxydeoxybenzoins and the use thereof to mask a bitter taste
12/26/2007EP1868437A1 Method of treating or preventing bone deterioration or osteoporosis
12/26/2007EP1722819B1 Method for solubilising peptide mixtures
12/26/2007EP1503797B1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity
12/26/2007EP1476139A4 Controlled release dosage forms
12/26/2007EP1426353B1 1,3-glyceride compound having two iodophenyl groups
12/26/2007EP1412384B1 Stable formulation of modified glp-1
12/26/2007EP1345620B1 Stable enzymatic wound debrider
12/26/2007EP1339430B1 Freeze-dried pantoprazole preparation and pantoprazole injection
12/26/2007EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
12/26/2007EP1294938B1 Cell-binding nucleic acid molecules (aptamers)
12/26/2007EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS
12/26/2007EP1235596B1 Use of lytic toxins and toxin conjugates
12/26/2007EP1085855A4 Enhanced intra vaginal devices
12/26/2007EP1045703A4 Stabilization of lipid:dna formulations during nebulization
12/26/2007EP0867190B1 Cytotoxin complexes comprising dipeptides
12/26/2007EP0817621B2 Pharmaceutical composition for transdermic delivery
12/26/2007CN101094863A Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
12/26/2007CN101094690A Compositions and methods for treating a posterior segment of an eye
12/26/2007CN101094669A Indometacin-containing adhesive patch
12/26/2007CN101094662A Hydrous adhesive patch
12/26/2007CN101094654A Solid, oral drug form which has been designed to prevent misuse
12/26/2007CN101094653A Solid, oral, microparticulate dosage form which has been designed to prevent misuse
12/26/2007CN101094649A Liposome formulations of boronic acid compounds
12/26/2007CN101094648A Liposomal formulation of bortezomib (ps-341)
12/26/2007CN101092499A Nano particle of enwrapping water-soluble active ingredient, and preparation method
12/26/2007CN101092484A Surface modified microballons of containing phosphazene, and preparation method
12/26/2007CN101092455A Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/26/2007CN101091799A Medicine in use for treating gastric cancer, and preparation method
12/26/2007CN101091796A Method for synthesizing lactide copolymer grafted by beta cyclodextrin
12/26/2007CN101091795A Prevention and treatment of synucleinopathic disease
12/26/2007CN101091792A Multi-dose erythropoietin formulations
12/26/2007CN101091738A Composition of medicine in use for treating cardiovascular disease and cerebrovascular disease, and preparation method
12/26/2007CN101091735A Gel preparation for treating subacute eczema and chronic eczema, and preparation method
12/26/2007CN101091721A Method for preparing new type asshide
12/26/2007CN101091714A Liposome of precursor containing ginsenoside Rh2, and preparation method
12/26/2007CN101091702A Oral disintegration tablet of Bromhexine Hydrochloride
12/26/2007CN101091701A Nimesulide drop pills prepared from solution drops under temperature of melting point
12/26/2007CN101091699A Powder mist agent containing Tiotropium Bromide, and preparation method
12/26/2007CN101091698A New type antineoplastic medicine, and preparation method
12/26/2007CN101091696A Self microemulsion preparation of Rubescensin A, and preparation method
12/26/2007CN101091695A Pharmaceutical formulation
12/26/2007CN100357314C Method for linking molecular substances
12/26/2007CN100356987C Thrombin-carrying bioabsorbable synthetic nonwoven fabric
12/26/2007CN100356984C 整联蛋白靶向的影像剂 Integrin targeting imaging agent
12/26/2007CN100356980C Chitosan drug carrying microsphere with uniform size, high embedding rate and high drug activity maintaining rate and its preparation process
12/26/2007CN100356978C Novel exendin agonist formulations and methods administration thereof
12/26/2007CN100356977C Regenerated human blood-platelet derivative growth factor gel
12/26/2007CN100356911C Compressed-shaping formulation for hypnosis
12/26/2007CN100356908C Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
12/26/2007CN100356907C Controlled release dosage forms using acrylic polymer, and process for making
12/26/2007CN100356906C Method for preparing hollow minisphere for lung administration
12/26/2007CN100356905C Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
12/26/2007CN100356871C Powder of amino acids and method for producing the same
12/25/2007US7312311 Attaching substances to microorganisms
12/25/2007US7312301 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
12/25/2007US7312244 For therapy of cancer, as antitumor agent
12/25/2007US7312207 Topical steroid cream formulations
12/25/2007US7312206 Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances
12/25/2007US7312196 Formulations for amylin agonist peptides
12/25/2007US7312194 Delivery systems
12/25/2007US7312193 Calcium phosphopeptide complexes
12/25/2007US7312192 For treating diseases including diabetes
12/25/2007US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007US7311932 sports drinks containing micronutrients, proteins and viable lactobacillus having positive effect on human intestinal mucous membranes
12/25/2007US7311928 Topical compositions containing tea tree oil for treatment of viral lesions
12/25/2007US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
12/25/2007US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/25/2007US7311908 Pharmaceutical compositions of fibrinolytic agent
12/25/2007US7311901 Hydrophilic comonomers of alkylene glycol, vinyl alcohols, vinylpyrrolidone, and/or acrylamide; hydrophobic comonoomer of lactic acid, glycolic acid, 6-hydroxycaproic acid, and/or dioxan-2-one substituted with tocopherol or cholesterol; stable micelles for delivery of anticarcinogenic agents
12/25/2007US7311892 Multidrug multiligand conjugates for targeted drug delivery
12/21/2007WO2007146296A1 Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders
12/21/2007WO2007145938A2 Beverages containing pheromone component
12/21/2007WO2007145919A2 Product and process for increasing compactibility of carbohydrates
12/21/2007WO2007145579A1 An adsorption device
12/21/2007WO2007145573A1 Metal oxide hydrogels and hydrosols, their preparation and use
1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 1712